Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19

This publication has 10 references indexed in Scilit:

• Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention
  Journal of the American Heart Association, 2021
• Anticoagulation and bleeding risk in patients with COVID-19
  Thrombosis Research, 2020
• Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19
  Circulation, 2020
• A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection
  Canadian Journal of Infectious Diseases and Medical Microbiology, 2020
• Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome
  Blood, 2020
• Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates
  Rheumatology International, 2020
• Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis
  Journal of Thrombosis and Thrombolysis, 2020
• Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019
  JAMA Network Open, 2020
• Colchicine inhibits neutrophil extracellular trap formation in acute coronary syndrome patients after percutaneous coronary intervention
  medRxiv, 2020
• A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases
  Arthritis Research & Therapy, 2014